SOSV Key Trends
Portfolio Companies
Afynia
Globally, one in ten women will suffer from endometriosis, a painful and debilitating gynecological condition. On average, women don’t get a proper diagnosis for five to twelve years after the onset of symptoms because, until now, the only reliable way to do so was via laparoscopic surgery that can cost over $20,000 and require three […]
Level Zero Health
Level Zero is a biotech company is creating the new default for measuring and tracking hormones. Leveraging cutting-edge advancements in biochemistry and nanotechnology, we are unblocking unprecedented access to hormone data, catalysing a paradigm shift in wellness, endocrine disorder management and personalise medicine.
Samphire Neuroscience
Samphire is building smart, wearable neurotechnology designed for women who want to be and feel productive regardless of their cycle-related challenges.
Aja Labs
Aja Labs creates biodegradable hair from plant fibers that behaves just like human hair using advances in polymer engineering and bioengineering to produce a sustainable and nourishing product. We put health at the forefront of R&D by partnering with nature, stylists, and wearers to engineer clean hair extensions.
Aksense
Aksense is providing a rapid test with a portable electrochemical biosensor to diagnose infections.
AMMA Pregnancy Tracker
Pregnancy Tracker is a one-stop mobile application to improve mental and physical health families worldwide.
BioAesthetics
BioAesthetics is developing a tissue engineered nipple-areolar complex (NAC) for patients with incomplete or removed NACs due to disease, surgery, or birth defects. BioAesthetics will provide an off-the-shelf-ready, human-derived, acellular NAC graft to plastic and reconstructive surgeons.
BryoSphere Biotechnologies
BryoSphere is harnessing 500 million years of moss evolution to make the next generation of skincare ingredients. Their genetically engineered moss biomanufacturing platform produces high-performance, plant-based bioactives that are too rare to source naturally and too expensive to produce at scale synthetically. The company’s first product, BryoBright™, features its hero molecule, aureusidin, for safe, effective […]
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the “Materials”), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.